In addition, animals injected with ELF3-overexpressing cancer cells had significantly lower tumor weights (p < 0.001) (Figure 6B) and ascites volumes (p < 0.001) (Figure 6C) than did the control animals, further supporting the tumor-inhibitory roles of ELF3 regarding ovarian cancer. This evidence concerns the gene ELF3 and ovarian carcinoma.